Xenon Pharma Private Limited
Xenon Pharma Private Limited is a Private Company limited by Shares company incorporated in 2005 and based in Delhi, India. Xenon Pharma Private Limited operates in Ayurvedic pharmaceutical preparations, manufacturing (NIC 24233) with authorized capital of ₹5.00 L and paid-up capital of ₹5.00 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Xenon Pharmaceuticals - Developer of small molecule drugs against rare channelopathies. Public Company. Raised a total funding of $85.7M over 4 rounds from 16 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Xenon Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +30d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Xenon Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 677932914 | State Bank of India(Bank) | ₹11.14 Cr | 04 Jul 2023 | Satisfied |
| 541877240 | HDFC Bank Ltd(Bank) | ₹24.43 Cr | 12 Mar 2021 | Open |
| 363630714 | State Bank of India(Bank) | ₹7.41 Cr | 04 Jul 2023 | Open |
| 282309735 | HDFC Bank Ltd(Bank) | ₹7.40 Cr | 12 Mar 2021 | Satisfied |
| 681566734 | Axis Bank Ltd(Bank) | ₹22.30 Cr | 19 Sep 2023 | Satisfied |
| 463429721 | HDFC Bank Ltd(Bank) | ₹3.01 Cr | 27 Jan 2022 | Open |
Charge IDs, lenders & amounts for Xenon Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹57.70 Cr | ₹-2.92 Cr | ₹51.06 Cr | ₹83.43 Cr | 38 |
| FY2023-24 | ₹52.79 Cr | ₹-2.39 Cr | ₹40.46 Cr | ₹72.45 Cr | 116 |
| FY2022-23 | ₹41.55 Cr | ₹-1.87 Cr | ₹25.50 Cr | ₹43.03 Cr | 81 |
| FY2021-22 | ₹39.80 Cr | ₹-80.31 L | ₹16.18 Cr | ₹40.04 Cr | 163 |
Audited financials & ratios for Xenon Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹57.70 Cr | ₹52.79 Cr | ₹41.55 Cr | ₹39.80 Cr |
| Other income | ₹1.86 Cr | ₹1.86 Cr | ₹21.68 L | ₹1.01 Cr |
| Total income | ₹59.56 Cr | ₹54.65 Cr | ₹41.77 Cr | ₹40.82 Cr |
| Total expenses | ₹63.30 Cr | ₹57.71 Cr | ₹44.16 Cr | ₹41.84 Cr |
| Profit before tax | ₹-3.80 Cr | ₹-3.11 Cr | ₹-2.43 Cr | ₹-1.04 Cr |
| Profit / (Loss) after tax | ₹-2.92 Cr | ₹-2.39 Cr | ₹-1.87 Cr | ₹-80.31 L |
| Balance sheet | ||||
| Equity / Net worth | ₹51.06 Cr | ₹40.46 Cr | ₹25.50 Cr | ₹16.18 Cr |
| Borrowings | ₹12.78 Cr | ₹14.94 Cr | ₹3.54 Cr | ₹8.02 Cr |
| Current liabilities | ₹17.14 Cr | ₹17.40 Cr | ₹7.58 Cr | ₹12.71 Cr |
| Total liabilities | ₹32.38 Cr | ₹31.99 Cr | ₹17.53 Cr | ₹23.86 Cr |
| Current assets | ₹29.45 Cr | ₹34.62 Cr | ₹19.46 Cr | ₹19.14 Cr |
| Cash & equivalents | ₹7.47 Cr | ₹10.43 Cr | ₹4.64 Cr | ₹4.87 Cr |
| Total assets | ₹83.43 Cr | ₹72.45 Cr | ₹43.03 Cr | ₹40.04 Cr |
| Employees | 38 | 116 | 81 | 163 |
Audited financials & ratios for Xenon Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹57.70 Cr | -5.0% | +22.0% | +12.6% |
| Profit after Tax | ₹-2.92 Cr | +11.3% | +15.6% | +3.7% |
| Net Worth | ₹51.06 Cr | +27.0% | +15.3% | -0.2% |
| Employees | 38 | +16.2% | -0.4% | +16.2% |
Audited financials & ratios for Xenon Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹57.70 Cr | ₹-2.92 Cr | -5.06% | -10.96% | -5.72% | -3.50% | 0.25 | ₹1.52 Cr |
| FY2023-24 | ₹52.79 Cr | ₹-2.39 Cr | -4.52% | -4.38% | -5.90% | -3.30% | 0.37 | ₹45.51 L |
| FY2022-23 | ₹41.55 Cr | ₹-1.87 Cr | -4.50% | -1.86% | -7.33% | -4.35% | 0.14 | ₹51.29 L |
| FY2021-22 | ₹39.80 Cr | ₹-80.31 L | -2.02% | +2.63% | -4.96% | -2.01% | 0.50 | ₹24.42 L |
Audited financials & ratios for Xenon Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 26,80,023 | 91.41% |
| Institutional Investors | 3 | 75,827 | 2.59% |
| Public & Others | 20 | 1,76,150 | 6.01% |
Promoter, institutional & public holding for Xenon Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
5 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.